Cargando…
Advancing the field of cancer immunotherapy: MIATA consensus guidelines become available to improve data reporting and interpretation for T-cell immune monitoring
Autores principales: | Hoos, Axel, Janetzki, Sylvia, Britten, Cedrik M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525600/ https://www.ncbi.nlm.nih.gov/pubmed/23264891 http://dx.doi.org/10.4161/onci.22308 |
Ejemplares similares
-
Immunological Monitoring to Rationally Guide AAV Gene Therapy
por: Britten, Cedrik Michael, et al.
Publicado: (2013) -
The immuno-oncology framework: Enabling a new era of cancer therapy
por: Hoos, Axel, et al.
Publicado: (2012) -
Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium
por: Britten, Cedrik Michael, et al.
Publicado: (2009) -
Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)
por: Janetzki, Sylvia, et al.
Publicado: (2007) -
Toward the harmonization of immune monitoring in clinical trials: Quo vadis?
por: Britten, C. M., et al.
Publicado: (2007)